CAS RN: 83-44-3 | Product Number: C0315
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
|Appearance||White powder to crystal|
|Purity(HPLC)(CAD)||min. 98.0 area%|
|Purity(Neutralization titration)||min. 98.0 %|
|Melting point||173.0 to 178.0 °C|
|Specific rotation [a]20/D||+54.0 to +58.0 deg(C=1, EtOH)|
|Solubility in Methanol||almost transparency|
|Melting Point||176 °C|
|Specific Rotation||56° (C=1,EtOH)|
|Hazard Statements||H302 : Harmful if swallowed.
H315 : Causes skin irritation.
H319 : Causes serious eye irritation.
|Precautionary Statements||P501 : Dispose of contents/ container to an approved waste disposal plant.
P270 : Do not eat, drink or smoke when using this product.
P264 : Wash skin thoroughly after handling.
P280 : Wear protective gloves/ eye protection/ face protection.
P337 + P313 : If eye irritation persists: Get medical advice/ attention.
P301 + P312 + P330 : IF SWALLOWED: Call a POISON CENTER/doctor if you feel unwell. Rinse mouth.
- Increased activity of group II phospholipase A2 in plasma in rat sodium deoxycholate induced acute pancreatitis
- Ursodeoxycholic acid prevents hepatic cytochrome P450 isozyme reduction in rats with deoxycholic acid-induced liver injury
- A rat model of chronic postinflammatory visceral pain induced by deoxycholic acid
Safety Data Sheet (SDS)
The requested SDS is not available.
Please Contact Us for more information.
C of A & Other Certificates
The requested analytical chart is not available. Sorry for the inconvenience.